Global Hepatitis B Vaccine (Recombinant) Market Research Report 2025(Status and Outlook)

March 2025 | 210 pages | ID: G064277F54A8EN
Bosson Research

Abstracts

Report Overview

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

This report provides a deep insight into the global Hepatitis B Vaccine (Recombinant) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hepatitis B Vaccine (Recombinant) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hepatitis B Vaccine (Recombinant) market in any manner.

Global Hepatitis B Vaccine (Recombinant) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GSK

Merck

Sanofi Pasteur

Dynavax Technologies

LG Life Sciences

KM Biologics

Shenzhen Kangtai Biological Products

Serum Institute

Market Segmentation (by Type)

10mcg/0.5ml

10mcg/ml

Market Segmentation (by Application)

Newborn

Adult

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Hepatitis B Vaccine (Recombinant) Market
• Overview of the regional outlook of the Hepatitis B Vaccine (Recombinant) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hepatitis B Vaccine (Recombinant) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hepatitis B Vaccine (Recombinant)
1.2 Key Market Segments
1.2.1 Hepatitis B Vaccine (Recombinant) Segment by Type
1.2.2 Hepatitis B Vaccine (Recombinant) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Hepatitis B Vaccine (Recombinant) Market Overview
2.1 Global Market Overview
2.1.1 Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Hepatitis B Vaccine (Recombinant) Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Hepatitis B Vaccine (Recombinant) Product Life Cycle
3.3 Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers (2020-2025)
3.4 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturers (2020-2025)
3.5 Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hepatitis B Vaccine (Recombinant) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Hepatitis B Vaccine (Recombinant) Manufacturing Sites, Area Served, Product Type
3.8 Hepatitis B Vaccine (Recombinant) Market Competitive Situation and Trends
3.8.1 Hepatitis B Vaccine (Recombinant) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hepatitis B Vaccine (Recombinant) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
4.1 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hepatitis B Vaccine (Recombinant) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hepatitis B Vaccine (Recombinant) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Hepatitis B Vaccine (Recombinant) Market
5.7 ESG Ratings of Leading Companies
6 Global Hepatitis B Vaccine (Recombinant) Market by Region
6.1 Global Hepatitis B Vaccine (Recombinant) Market Size by Region
6.1.1 Global Hepatitis B Vaccine (Recombinant) Market Size by Region
6.1.2 Global Hepatitis B Vaccine (Recombinant) Market Size Market Share by Region
6.2 Global Hepatitis B Vaccine (Recombinant) Sales by Region
6.2.1 Global Hepatitis B Vaccine (Recombinant) Sales by Region
6.2.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region
7 North America Market Overview
7.1 North America Hepatitis B Vaccine (Recombinant) Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Hepatitis B Vaccine (Recombinant) Market Size by Type
7.3 North America Hepatitis B Vaccine (Recombinant) Market Size by Application
8 Europe Market Overview
8.1 Europe Hepatitis B Vaccine (Recombinant) Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Hepatitis B Vaccine (Recombinant) Market Size by Type
8.3 Europe Hepatitis B Vaccine (Recombinant) Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size by Type
9.3 Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size by Application
10 South America Market Overview
10.1 South America Hepatitis B Vaccine (Recombinant) Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Hepatitis B Vaccine (Recombinant) Market Size by Type
10.3 South America Hepatitis B Vaccine (Recombinant) Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Type
11.3 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Application
12 Hepatitis B Vaccine (Recombinant) Market Production by Region
12.1 Global Production of Hepatitis B Vaccine (Recombinant) by Region(2020-2025)
12.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2020-2025)
12.3 Global Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Hepatitis B Vaccine (Recombinant) Production
12.4.1 North America Hepatitis B Vaccine (Recombinant) Production Growth Rate (2020-2025)
12.4.2 North America Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Hepatitis B Vaccine (Recombinant) Production
12.5.1 Europe Hepatitis B Vaccine (Recombinant) Production Growth Rate (2020-2025)
12.5.2 Europe Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Hepatitis B Vaccine (Recombinant) Production (2020-2025)
12.6.1 Japan Hepatitis B Vaccine (Recombinant) Production Growth Rate (2020-2025)
12.6.2 Japan Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Hepatitis B Vaccine (Recombinant) Production (2020-2025)
12.7.1 China Hepatitis B Vaccine (Recombinant) Production Growth Rate (2020-2025)
12.7.2 China Hepatitis B Vaccine (Recombinant) Production, Revenue, Price and Gross Margin (2020-2025)
13 Hepatitis B Vaccine (Recombinant) Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2020-2033)
13.3 Global Hepatitis B Vaccine (Recombinant) Market Size Market Share by Type (2020-2033)
13.4 Global Hepatitis B Vaccine (Recombinant) Price by Type (2020-2033)
14 Hepatitis B Vaccine (Recombinant) Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Hepatitis B Vaccine (Recombinant) Market Sales by Application (2020-2033)
14.3 Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application (2020-2033)
14.4 Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 GSK
15.1.1 GSK Basic Information
15.1.2 GSK Hepatitis B Vaccine (Recombinant) Product Overview
15.1.3 GSK Hepatitis B Vaccine (Recombinant) Product Market Performance
15.1.4 GSK Business Overview
15.1.5 GSK SWOT Analysis
15.1.6 GSK Recent Developments
15.2 Merck
15.2.1 Merck Basic Information
15.2.2 Merck Hepatitis B Vaccine (Recombinant) Product Overview
15.2.3 Merck Hepatitis B Vaccine (Recombinant) Product Market Performance
15.2.4 Merck Business Overview
15.2.5 Merck SWOT Analysis
15.2.6 Merck Recent Developments
15.3 Sanofi Pasteur
15.3.1 Sanofi Pasteur Basic Information
15.3.2 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Overview
15.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Market Performance
15.3.4 Sanofi Pasteur Business Overview
15.3.5 Sanofi Pasteur SWOT Analysis
15.3.6 Sanofi Pasteur Recent Developments
15.4 Dynavax Technologies
15.4.1 Dynavax Technologies Basic Information
15.4.2 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Overview
15.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Market Performance
15.4.4 Dynavax Technologies Business Overview
15.4.5 Dynavax Technologies Recent Developments
15.5 LG Life Sciences
15.5.1 LG Life Sciences Basic Information
15.5.2 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Overview
15.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Market Performance
15.5.4 LG Life Sciences Business Overview
15.5.5 LG Life Sciences Recent Developments
15.6 KM Biologics
15.6.1 KM Biologics Basic Information
15.6.2 KM Biologics Hepatitis B Vaccine (Recombinant) Product Overview
15.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Product Market Performance
15.6.4 KM Biologics Business Overview
15.6.5 KM Biologics Recent Developments
15.7 Shenzhen Kangtai Biological Products
15.7.1 Shenzhen Kangtai Biological Products Basic Information
15.7.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Overview
15.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Market Performance
15.7.4 Shenzhen Kangtai Biological Products Business Overview
15.7.5 Shenzhen Kangtai Biological Products Recent Developments
15.8 Serum Institute
15.8.1 Serum Institute Basic Information
15.8.2 Serum Institute Hepatitis B Vaccine (Recombinant) Product Overview
15.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Product Market Performance
15.8.4 Serum Institute Business Overview
15.8.5 Serum Institute Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 4. Global Hepatitis B Vaccine (Recombinant) Market Size by Application (M USD)
Table 5. Hepatitis B Vaccine (Recombinant) Market Size Comparison by Region (M USD)
Table 6. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hepatitis B Vaccine (Recombinant) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccine (Recombinant) as of 2024)
Table 11. Global Market Hepatitis B Vaccine (Recombinant) Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Hepatitis B Vaccine (Recombinant) Manufacturing Sites and Area Served
Table 13. Manufacturers Hepatitis B Vaccine (Recombinant) Product Type
Table 14. Global Hepatitis B Vaccine (Recombinant) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis B Vaccine (Recombinant) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Hepatitis B Vaccine (Recombinant) Market Size Comparison by Region (M USD)
Table 26. Global Hepatitis B Vaccine (Recombinant) Market Size by Region (2020-2033) & (M USD)
Table 27. Global Hepatitis B Vaccine (Recombinant) Market Size Market Share by Region (2020-2033)
Table 28. Global Hepatitis B Vaccine (Recombinant) Sales by Region (2020-2033) & (K MT)
Table 29. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2020-2033)
Table 30. North America Hepatitis B Vaccine (Recombinant) Market Size by Country (2020-2033) & (M USD)
Table 31. North America Hepatitis B Vaccine (Recombinant) Sales by Country (2020-2033) & (K MT)
Table 32. North America Hepatitis B Vaccine (Recombinant) Sales by Type (K MT)
Table 33. North America Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 34. North America Hepatitis B Vaccine (Recombinant) Sales (K MT) by Type (2020-2033)
Table 35. North America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type (2020-2033)
Table 36. North America Hepatitis B Vaccine (Recombinant) Sales by Application (K MT)
Table 37. North America Hepatitis B Vaccine (Recombinant) Market Size by Application (M USD)
Table 38. North America Hepatitis B Vaccine (Recombinant) Sales (K MT) by Application (2020-2033)
Table 39. North America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application (2020-2033)
Table 40. Europe Hepatitis B Vaccine (Recombinant) Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2020-2033) & (K MT)
Table 42. Europe Hepatitis B Vaccine (Recombinant) Sales by Type (K MT)
Table 43. Europe Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 44. Europe Hepatitis B Vaccine (Recombinant) Sales (K MT) by Type (2020-2033)
Table 45. Europe Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type (2020-2033)
Table 46. Europe Hepatitis B Vaccine (Recombinant) Sales by Application (K MT)
Table 47. Europe Hepatitis B Vaccine (Recombinant) Market Size by Application (M USD)
Table 48. Europe Hepatitis B Vaccine (Recombinant) Sales (K MT) by Application (2020-2033)
Table 49. Europe Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales by Type (K MT)
Table 53. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 54. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales by Application (K MT)
Table 57. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size by Application (M USD)
Table 58. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application (2020-2025)
Table 60. South America Hepatitis B Vaccine (Recombinant) Market Size by Country (2020-2033) & (M USD)
Table 61. South America Hepatitis B Vaccine (Recombinant) Sales by Country (2020-2033) & (K MT)
Table 62. South America Hepatitis B Vaccine (Recombinant) Sales by Type (K MT)
Table 63. South America Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 64. South America Hepatitis B Vaccine (Recombinant) Sales (K MT) by Type (2020-2033)
Table 65. South America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type (2020-2033)
Table 66. South America Hepatitis B Vaccine (Recombinant) Sales by Application (K MT)
Table 67. South America Hepatitis B Vaccine (Recombinant) Market Size by Application (M USD)
Table 68. South America Hepatitis B Vaccine (Recombinant) Sales (K MT) by Application (2020-2033)
Table 69. South America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Type (K MT)
Table 73. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 74. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Application (K MT)
Table 77. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Application (M USD)
Table 78. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application (2020-2033)
Table 80. Global Hepatitis B Vaccine (Recombinant) Production (K MT) by Region(2020-2025)
Table 81. Global Hepatitis B Vaccine (Recombinant) Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2020-2025)
Table 83. Global Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Hepatitis B Vaccine (Recombinant) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Hepatitis B Vaccine (Recombinant) Sales by Type (K MT)
Table 89. Global Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Table 90. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) by Type (2020-2033)
Table 91. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2020-2033)
Table 92. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type (2020-2033)
Table 93. Global Hepatitis B Vaccine (Recombinant) Market Size Share by Type (2020-2033)
Table 94. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) by Application
Table 95. Global Hepatitis B Vaccine (Recombinant) Market Size by Application(M USD)
Table 96. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2020-2033) & (K MT)
Table 97. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2020-2033)
Table 98. Global Hepatitis B Vaccine (Recombinant) Market Size by Application (2020-2033) & (M USD)
Table 99. Global Hepatitis B Vaccine (Recombinant) Market Share by Application (2020-2033)
Table 100. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2020-2033)
Table 101. GSK Basic Information
Table 102. GSK Hepatitis B Vaccine (Recombinant) Product Overview
Table 103. GSK Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. GSK Business Overview
Table 105. GSK SWOT Analysis
Table 106. GSK Recent Developments
Table 107. Merck Basic Information
Table 108. Merck Hepatitis B Vaccine (Recombinant) Product Overview
Table 109. Merck Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Merck Business Overview
Table 111. Merck SWOT Analysis
Table 112. Merck Recent Developments
Table 113. Sanofi Pasteur Basic Information
Table 114. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Overview
Table 115. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Sanofi Pasteur Business Overview
Table 117. Sanofi Pasteur SWOT Analysis
Table 118. Sanofi Pasteur Recent Developments
Table 119. Dynavax Technologies Basic Information
Table 120. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Overview
Table 121. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Dynavax Technologies Business Overview
Table 123. Dynavax Technologies Recent Developments
Table 124. LG Life Sciences Basic Information
Table 125. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Overview
Table 126. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. LG Life Sciences Business Overview
Table 128. LG Life Sciences Recent Developments
Table 129. KM Biologics Basic Information
Table 130. KM Biologics Hepatitis B Vaccine (Recombinant) Product Overview
Table 131. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. KM Biologics Business Overview
Table 133. KM Biologics Recent Developments
Table 134. Shenzhen Kangtai Biological Products Basic Information
Table 135. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Overview
Table 136. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Shenzhen Kangtai Biological Products Business Overview
Table 138. Shenzhen Kangtai Biological Products Recent Developments
Table 139. Serum Institute Basic Information
Table 140. Serum Institute Hepatitis B Vaccine (Recombinant) Product Overview
Table 141. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Serum Institute Business Overview
Table 143. Serum Institute Recent Developments
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccine (Recombinant)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD), 2024-2033
Figure 5. Global Hepatitis B Vaccine (Recombinant) Market Size (M USD) (2020-2033)
Figure 6. Global Hepatitis B Vaccine (Recombinant) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis B Vaccine (Recombinant) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hepatitis B Vaccine (Recombinant) Product Life Cycle
Figure 13. Hepatitis B Vaccine (Recombinant) Sales Share by Manufacturers in 2024
Figure 14. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Manufacturers in 2024
Figure 15. Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Hepatitis B Vaccine (Recombinant) Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hepatitis B Vaccine (Recombinant) Revenue in 2024
Figure 18. Industry Chain Map of Hepatitis B Vaccine (Recombinant)
Figure 19. Global Hepatitis B Vaccine (Recombinant) Market PEST Analysis
Figure 20. Global Hepatitis B Vaccine (Recombinant) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Hepatitis B Vaccine (Recombinant) Market Size by Region
Figure 27. Global Hepatitis B Vaccine (Recombinant) Market Size Market Share by Region (2020-2033)
Figure 28. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Country
Figure 33. USA Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Hepatitis B Vaccine (Recombinant) Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Hepatitis B Vaccine (Recombinant) Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Hepatitis B Vaccine (Recombinant) Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Hepatitis B Vaccine (Recombinant) Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Hepatitis B Vaccine (Recombinant) Market Size (M USD)by Type
Figure 40. North America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Country
Figure 45. Germany Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type
Figure 56. Europe Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Country
Figure 61. China Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type
Figure 72. Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Country
Figure 77. Brazil Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type
Figure 84. South America Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Country
Figure 89. Saudi Arabia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Hepatitis B Vaccine (Recombinant) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Type
Figure 100. Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size (M USD) by Application
Figure 101. Global Hepatitis B Vaccine (Recombinant) Production Market Share by Region (2020-2025)
Figure 102. North America Hepatitis B Vaccine (Recombinant) Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Hepatitis B Vaccine (Recombinant) Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Hepatitis B Vaccine (Recombinant) Production (K MT) Growth Rate (2020-2025)
Figure 105. China Hepatitis B Vaccine (Recombinant) Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Hepatitis B Vaccine (Recombinant) Market Size by Type (M USD)
Figure 108. Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type (2020-2033)
Figure 109. Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type in 2024
Figure 110. Market Size Share of Hepatitis B Vaccine (Recombinant) by Type (2020-2033)
Figure 111. Market Size Share of Hepatitis B Vaccine (Recombinant) by Type in 2024
Figure 112. Global Hepatitis B Vaccine (Recombinant) Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Hepatitis B Vaccine (Recombinant) Market Size by Application(M USD)
Figure 115. Global Hepatitis B Vaccine (Recombinant) Market Share by Application
Figure 116. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2020-2033)
Figure 117. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application in 2024
Figure 118. Global Hepatitis B Vaccine (Recombinant) Market Share by Application (2020-2033)
Figure 119. Global Hepatitis B Vaccine (Recombinant) Market Share by Application in 2024
Figure 120. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate by Application (2020-2033)